Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
暂无分享,去创建一个
Olivier Lantz | Laurence Zitvogel | Sebastian Amigorena | Alain Spatz | Caroline Robert | Fabrice André | Thierry Dorval | L. Zitvogel | N. Chaput | F. André | C. Robert | T. Tursz | C. Borg | J. Le Pecq | O. Lantz | B. Escudier | S. Novault | S. Amigorena | A. Spatz | C. Bonnerot | C. Flament | T. Dorval | Bernard Escudier | E. Angevin | Thomas Tursz | Nathalie Chaput | C. Boccaccio | Marie-Pierre Caby | Christian Bonnerot | O. Dhellin | Caroline Flament | Eric Angevin | Jean-Bernard Le Pecq | Sophie Novault | Christophe Leboulaire | Christophe Borg | Catherine Boccaccio | Olivier Dhellin | Mojgan Movassagh | Sophie Piperno | Vincent Serra | Nancy Valente | M. Movassagh | V. Serra | N. Valente | C. Leboulaire | Marie-Pierre Caby | S. Piperno
[1] J. Le Pecq,et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer , 2005, Journal of Translational Medicine.
[2] J. Fay,et al. Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic Cells , 2004, The Journal of experimental medicine.
[3] E. Wagner,et al. IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules1 , 2004, The Journal of Immunology.
[4] L. Zitvogel,et al. Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection 1 , 2004, The Journal of Immunology.
[5] L. Zitvogel,et al. Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells 1 , 2004, The Journal of Immunology.
[6] J. Davoust,et al. ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells , 2003, Nature.
[7] P. Paz,et al. Exosomes as a Tumor Vaccine: Enhancing Potency Through Direct Loading of Antigenic Peptides , 2003, Journal of immunotherapy.
[8] R. Steinman,et al. Single Injection of CD34+ Progenitor-Derived Dendritic Cell Vaccine Can Lead to Induction of T-Cell Immunity in Patients With Stage IV Melanoma , 2003, Journal of immunotherapy.
[9] J. Le Pecq,et al. Production and characterization of clinical grade exosomes derived from dendritic cells. , 2002, Journal of immunological methods.
[10] C. Théry,et al. Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes , 2002, Nature Immunology.
[11] Laurence Zitvogel,et al. Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.
[12] G. Schuler,et al. Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells , 2002, The Journal of experimental medicine.
[13] Drew M. Pardoll,et al. Vaccines: Spinning molecular immunology into successful immunotherapy , 2002, Nature Reviews Immunology.
[14] R. Steinman,et al. Active immunization against cancer with dendritic cells: The near future , 2001, International journal of cancer.
[15] L. Zitvogel,et al. Dendritic Cell Maturation Overrules H-2d–Mediated Natural Killer T (Nkt) Cell Inhibition , 2001, The Journal of experimental medicine.
[16] R. Steinman,et al. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. , 2001, Cancer research.
[17] P. Coulie,et al. A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] Gerold Schuler,et al. Dendritic Cells as Vectors for Therapy , 2001, Cell.
[19] Frank O. Nestle,et al. Dendritic cells: On the move from bench to bedside , 2001, Nature Medicine.
[20] P. Ricciardi-Castagnoli,et al. Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.
[21] C. Melief,et al. Antigen Loading of MHC Class I Molecules in the Endocytic Tract , 2001, Traffic.
[22] M. Mason,et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. , 2001, Journal of immunological methods.
[23] H. Geuze,et al. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.
[24] A. Enk,et al. Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells1 , 2000, The Journal of Immunology.
[25] R. Steinman,et al. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. , 1999, The Journal of clinical investigation.
[26] C. Chow,et al. Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] P. Coulie,et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1 , 1999, International journal of cancer.
[28] H. Geuze,et al. Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes* , 1998, The Journal of Biological Chemistry.
[29] Laurence Zitvogel,et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.
[30] H. Rammensee,et al. Analysis of the T cell response to tumor and viral peptide antigens by an IFNγ‐ELISPOT assay , 1997 .
[31] H. Rammensee,et al. Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay. , 1997, International journal of cancer.
[32] C. Melief,et al. B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.
[33] F. Brasseur,et al. Expression of mage genes by non‐small‐cell lung carcinomas , 1994, International journal of cancer.